Accurate and sensitive antibody detection remains critical for advanced COVID-19 diagnostics and monitoring SARS-CoV-2 immunity. This study presents a highly sensitive technique for detecting anti-SARS-CoV-2 antibodies in human serum using an integrated photonic sensing platform. The platform utilizes disposable one-dimensional photonic crystal biochips engineered to sustain Bloch Surface Waves. The biochips are integrated into a custom-made optical set-up, which is capable of dual-mode detection: label-free refractometry and label-based fluorescence. Tests on human serum, including negative controls and positive samples from a recovered COVID-19 patient, confirmed the platform’s effective performance. In fluorescence mode, clear discrimination between positive and negative samples was achieved down to a 1:104 serum dilution, with an optimal operating range centered around 1:103 dilution. These results demonstrate the potential of the technique as a highly sensitive and versatile platform for antibody detection, with significant relevance for advanced COVID-19 diagnostics.
Highly Sensitive Detection of Anti-SARS-CoV-2 Antibodies in Human Serum Using Bloch Surface Wave Biosensor / Gaganina, A., Occhicone, A., Chiappetta, D., Di Matteo, P., Danz, N., Allegretti, M., Munzert, P., Mandoj, C., Michelotti, F., Sinibaldi, A.. - In: SENSORS. - ISSN 1424-8220. - 26:26(2026). [10.3390/s26010046]
Highly Sensitive Detection of Anti-SARS-CoV-2 Antibodies in Human Serum Using Bloch Surface Wave Biosensor
Gaganina, Anastasiia;Occhicone, Agostino;Chiappetta, Daniele;Di Matteo, Paola;Michelotti, Francesco;Sinibaldi, Alberto
2026
Abstract
Accurate and sensitive antibody detection remains critical for advanced COVID-19 diagnostics and monitoring SARS-CoV-2 immunity. This study presents a highly sensitive technique for detecting anti-SARS-CoV-2 antibodies in human serum using an integrated photonic sensing platform. The platform utilizes disposable one-dimensional photonic crystal biochips engineered to sustain Bloch Surface Waves. The biochips are integrated into a custom-made optical set-up, which is capable of dual-mode detection: label-free refractometry and label-based fluorescence. Tests on human serum, including negative controls and positive samples from a recovered COVID-19 patient, confirmed the platform’s effective performance. In fluorescence mode, clear discrimination between positive and negative samples was achieved down to a 1:104 serum dilution, with an optimal operating range centered around 1:103 dilution. These results demonstrate the potential of the technique as a highly sensitive and versatile platform for antibody detection, with significant relevance for advanced COVID-19 diagnostics.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


